{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:37:48Z","timestamp":1788305868100,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hand Surgery and Rehabilitation"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.hansur.2026.102589","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T19:11:29Z","timestamp":1769713889000},"page":"102589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Relationship between glucagon-like peptide-1 receptor agonist use and incidence of trigger finger in patients with type 2 diabetes"],"prefix":"10.1016","volume":"45","author":[{"given":"Kyle","family":"Stump","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Morar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec","family":"Talsania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianly","family":"Centeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasya","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Wiekrykas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hansur.2026.102589_bib0005","doi-asserted-by":"crossref","DOI":"10.2337\/dci25-0012","article-title":"Upper-limb complications in diabetes: a narrative review","author":"Braffett","year":"2025","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.hansur.2026.102589_bib0010","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1001\/jama.2022.8481","article-title":"Common hand conditions: a review","volume":"327","author":"Currie","year":"2022","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.hansur.2026.102589_bib0015","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2337\/dc23-0063","article-title":"Upper-extremity impairments in Type 1 diabetes: results from a controlled nationwide study","volume":"46","author":"Wagner","year":"2023","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.hansur.2026.102589_bib0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jhsa.2018.03.045","article-title":"Management of diabetic trigger finger","volume":"44","author":"Kuczmarski","year":"2019","journal-title":"J Hand Surg Am"},{"issue":"1","key":"10.1016\/j.hansur.2026.102589_bib0025","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyad187","article-title":"Hyperglycaemia is a causal risk factor for upper limb pathologies","volume":"53","author":"Green","year":"2024","journal-title":"Int J Epidemiol"},{"issue":"11","key":"10.1016\/j.hansur.2026.102589_bib0030","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dc22-0829","article-title":"High HbA1c levels are associated with development of trigger finger in Type 1 and Type 2 diabetes: an observational register-based study from Sweden","volume":"45","author":"Rydberg","year":"2022","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.hansur.2026.102589_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3417","article-title":"The impact of type 2 diabetes on the development of tendinopathy","volume":"37","author":"Cannata","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"issue":"7","key":"10.1016\/j.hansur.2026.102589_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271770","article-title":"Descriptive transcriptome analysis of tendon derived fibroblasts following in-vitro exposure to advanced glycation end products","volume":"17","author":"Patel","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.hansur.2026.102589_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1491633","article-title":"The impact of diabetes mellitus on tendon pathology: a review","volume":"15","author":"Xu","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.hansur.2026.102589_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108270","article-title":"Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities","volume":"239","author":"Shao","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.hansur.2026.102589_bib0055","doi-asserted-by":"crossref","first-page":"e656","DOI":"10.1016\/j.jse.2024.11.041","article-title":"GLP-1 agonist use increases the incidence of adhesive capsulitis and odds of requiring operative management in type 2 diabetes patients: a matched propensity score analysis","volume":"34","author":"Bergstein","year":"2025","journal-title":"J Shoulder Elbow Surg"},{"issue":"4","key":"10.1016\/j.hansur.2026.102589_bib0060","doi-asserted-by":"crossref","first-page":"420e","DOI":"10.1097\/PRS.0000000000007156","article-title":"Increased rate of complications following trigger finger release in diabetic patients","volume":"146","author":"Federer","year":"2020","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"10.1016\/j.hansur.2026.102589_bib0065","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jhsa.2021.05.009","article-title":"Wound healing complications in diabetic patients undergoing carpal tunnel and trigger finger releases: a retrospective cohort study","volume":"46","author":"Gundlach","year":"2021","journal-title":"J Hand Surg Am"},{"issue":"8","key":"10.1016\/j.hansur.2026.102589_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00264-022-05440-y","article-title":"Association between diabetes mellitus and risk of infection after trigger finger release: a systematic review and meta-analysis","volume":"46","author":"Atthakomol","year":"2022","journal-title":"Int Orthop"},{"key":"10.1016\/j.hansur.2026.102589_bib0075","series-title":"The global health research network","year":"2024"},{"issue":"9","key":"10.1016\/j.hansur.2026.102589_bib0080","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jacc.2020.05.037","article-title":"2020 expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with Type 2 diabetes: a report of the American college of cardiology solution set oversight committee","volume":"76","author":"Das","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.hansur.2026.102589_bib0085","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1111\/dom.16366","article-title":"The effect of GLP-1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: a systematic review and meta-analysis","volume":"27","author":"Ren","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"15","key":"10.1016\/j.hansur.2026.102589_bib0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158214","article-title":"Impact of selected glucagon-like peptide-1 receptor agonists on serum lipids, adipose tissue, and muscle metabolism-a narrative review","volume":"25","author":"Szekeres","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.hansur.2026.102589_bib0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031854","article-title":"Impact of glucagon-like peptide 1 receptor agonists on biochemical markers of the initiation of atherosclerotic process","volume":"25","author":"Hachu\u0142a","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.hansur.2026.102589_bib0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119324","article-title":"Therapeutic mechanisms and clinical effects of glucagon-like peptide 1 receptor agonists in nonalcoholic fatty liver disease","volume":"24","author":"Lee","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hansur.2026.102589_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103864","article-title":"Glucagon-Like Peptide-1 (GLP-1) receptor agonists in rheumatology: a review of current evidence and future directions","author":"Bilgin","year":"2025","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.hansur.2026.102589_bib0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/phar.70005","article-title":"The potential role of GLP-1 receptor agonists in osteoarthritis","volume":"45","author":"Ryan","year":"2025","journal-title":"Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.hansur.2026.102589_bib0115","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/dom.14399","article-title":"Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis of randomised controlled trials","volume":"23","author":"Bray","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.hansur.2026.102589_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 receptor agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.hansur.2026.102589_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113236","article-title":"Application of glucagon-like peptide-1 receptor antagonists in fibrotic diseases","volume":"152","author":"Yang","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"17","key":"10.1016\/j.hansur.2026.102589_bib0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713540","article-title":"Exploratory study analyzing the urinary peptidome of T2DM patients suggests changes in ECM but also inflammatory and metabolic pathways following GLP-1R agonist treatment","volume":"24","author":"Lohia","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hansur.2026.102589_bib0135","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.24.01287","article-title":"GLP-1 receptor agonists in orthopaedic surgery: implications for perioperative and outcomes: an orthopaedic surgeon\u2019s perspective","author":"Ramanathan","year":"2025","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.hansur.2026.102589_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjsurg.2024.116119","article-title":"A systematic review of the use of GLP-1 receptor agonists in surgery","volume":"240","author":"Ihnat","year":"2025","journal-title":"Am J Surg"},{"key":"10.1016\/j.hansur.2026.102589_bib0145","doi-asserted-by":"crossref","DOI":"10.5435\/JAAOS-D-24-01284","article-title":"The effects of glucagon-like peptide-1 agonist therapy on risk of infection, fracture, and early revision in primary total joint arthroplasty","author":"Levidy","year":"2025","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.hansur.2026.102589_bib0150","article-title":"The association between glucagon-like peptide-1 receptor agonists and postoperative complications after arthroplasty: a systematic review and meta-analysis","author":"Chan","year":"2025","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.hansur.2026.102589_bib0155","article-title":"Impact of glucagon-like peptide-1 receptor agonists on postoperative outcomes in arthroplasty: a systematic review","author":"Lee","year":"2025","journal-title":"J Arthroplasty"},{"issue":"7","key":"10.1016\/j.hansur.2026.102589_bib0160","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/dom.15038","article-title":"Clinical characteristics, treatment patterns, and persistence in individuals with type 2 Diabetes initiating A glucagon-like peptide-1 receptor agonist: a retrospective analysis of the Diabetes Prospective Follow-Up Registry","volume":"25","author":"Jung","year":"2023","journal-title":"Diabetes Obes Metab."}],"container-title":["Hand Surgery and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468122926000241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468122926000241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:45:26Z","timestamp":1775821526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468122926000241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2468122926000241"],"URL":"https:\/\/doi.org\/10.1016\/j.hansur.2026.102589","relation":{},"ISSN":["2468-1229"],"issn-type":[{"value":"2468-1229","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between glucagon-like peptide-1 receptor agonist use and incidence of trigger finger in patients with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Hand Surgery and Rehabilitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hansur.2026.102589","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 SFCM. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102589"}}